Showing results (311-320 of 1,003) with videos related to

Sort By:
Pageof 101
Cardiovascular Therapeutics|June 3, 2015
Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysisXiuli Xu, Choumi T Alida, Bo Yu
Cardiovascular Therapeutics|June 3, 2015
The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic DyslipidemiaRobert Krysiak, Wojciech Gilowski, Bogusław Okopien
Cardiovascular Therapeutics|August 5, 2016
Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivorsAnthony S Gunnell, Joseph Hung, Matthew W Knuiman, et al.
Cardiovascular Therapeutics|February 27, 2017
Prevalence of in-hospital nonsteroidal antiinflammatory drug exposure in patients with a primary diagnosis of heart failurePaulino A Alvarez, David Putney, Richard Ogunti, et al.
Cardiovascular Therapeutics|June 22, 2017
Pharmacokinetics and pharmacodynamics of bococizumab, a monoclonal antibody to PCSK9, after single subcutaneous injection at three sites [NCT 02043301]Ellen Q Wang, Anna Plotka, Joanne Salageanu, et al.
Cardiovascular Therapeutics|February 27, 2010
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trialsHenry Krum, John J V McMurray, Edward Horton, et al.
Cardiovascular Therapeutics|September 9, 2016
Onset-to-device time of patients who arrive at off-hours: Importance of prehospital management and public awareness for patients with ST-segment elevation myocardial infarctionYukio Mizuguchi, Hiroki Shibutani, Sho Hashimoto, et al.
Cardiovascular Therapeutics|May 19, 2017
Endothelial damage effects of circulating microparticles from patients with stable angina are reduced by aspirin through ERK/p38 MAPKs pathwaysGong Cheng, Xue-Feng Shan, Xu-Lang Wang, et al.
Cardiovascular Therapeutics|April 3, 2018
microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expressionChun Yang, Houda Tahiri, Chenrongrong Cai, et al.
Cardiovascular Therapeutics|July 15, 2018
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control studyLuca Zanella, Giacomo Zoppellaro, Lucia Marigo, et al.
Pageof 101